Autres langues KPC Pharmaceuticals,Inc.

Actions

600422

CNE0000015P8

Produits pharmaceutiques

Cours en clôture Shanghai S.E. 21/09/2026			Varia. 5j.	Varia. 1 janv.
8,320 ^CNY	+2,21%		+0,48%	-33,76%

21/08	KPC Pharmaceuticals, Inc. publie ses résultats pour le premier semestre clos le 30 juin 2026	CI
27/07	KPC Pharmaceuticals cède sa participation dans Nanjing Leads Biolabs	MT

Autres langues

21/08	KPC Pharmaceuticals,Inc. Reports Earnings Results for the Half Year Ended June 30, 2026
27/07	KPC Pharmaceuticals to Divest Stake in Nanjing Leads Biolabs
24/04	KPC Pharmaceuticals,Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026
19/03	China Resources Pharmaceutical says KPC Pharmaceuticals proposes dividend of RMB1.80 per 10 shares
19/03	KPC Pharmaceuticals,Inc. Proposes Cash Dividend
06/02	China Resources Pharmaceutical updates on KPC Pharmaceuticals
06/02	KPC Pharmaceutical's 2025 Profit Slips 46%
06/02	KPC Pharmaceuticals,Inc. Reports Earnings Results for the Full Year Ended December 31, 2025
06/01	KPC Pharmaceuticals Appoints Chair
05/01	KPC Pharmaceuticals elects chairman
24/10/25	KPC Pharmaceuticals,Inc. Reports Earnings Results for the Nine Months Ended September 30, 2025
24/10/25	China Resources Pharmaceutical says 9m net profit for KPC Pharmaceuticals is RMB323.4 mln
18/08/25	KPC Pharmaceuticals' H1 Profit Shrinks 27%
15/08/25	China Resources Pharmaceutical posts HY results for KPC Pharmaceuticals
15/08/25	KPC Pharmaceuticals,Inc. Reports Earnings Results for the Half Year Ended June 30, 2025
22/07/25	KPC Pharmaceuticals' Unit Gets Drug Certificate for Sevelamer Carbonate Dry Suspension
20/06/25	KPC Pharmaceuticals,Inc.(SHSE:600422) dropped from Shanghai Stock Exchange Health Care Sector Index
29/04/25	KPC Pharmaceuticals' Q1 Profit Declines 31%
28/04/25	KPC Pharmaceuticals,Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025
12/03/25	KPC Pharmaceuticals' 2024 Profit Rises 20%
11/03/25	China Resources Pharmaceutical Announces KPC Pharmaceuticals FY Results
11/03/25	KPC Pharmaceuticals,Inc. Proposes Cash Dividend
11/03/25	KPC Pharmaceuticals,Inc. Reports Earnings Results for the Full Year Ended December 31, 2024
03/03/25	KPC Pharmaceuticals Gets Approval for Post-Surgery Delirium Drug Trial
10/02/25	KPC Pharmaceuticals Records 46% Higher Net Attributable Profit in 2024